Aegerion Pharmaceuticals Announces Presentation at the 31st Annual J.P. Morgan Healthcare Conference
[at noodls] – CAMBRIDGE, Mass., Jan. 3, 2013 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc.(Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics … moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboardSee who Aegerion is hiring next, click here to view […]